Current Status and Future Perspectives of Liquid Biopsy in Small Cell Lung Cancer
Approximately 19% of all cancer-related deaths are due to lung cancer, which is the leading cause of mortality worldwide. Small cell lung cancer (SCLC) affects approximately 15% of patients diagnosed with lung cancer. SCLC is characterized by aggressiveness; the majority of SCLC patients present wit...
Main Authors: | Patricia Mondelo-Macía, Jorge García-González, Luis León-Mateos, Adrián Castillo-García, Rafael López-López, Laura Muinelo-Romay, Roberto Díaz-Peña |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/1/48 |
Similar Items
-
Liquid biopsy: current technology and clinical applications
by: Mina Nikanjam, et al.
Published: (2022-09-01) -
BL-MOL-AR Project, Preliminary Results about Liquid Biopsy: Molecular Approach Experience and Research Activity in Oncological Settings
by: Pancrazzi Pancrazzi, et al.
Published: (2023-09-01) -
Advances in early detection methods for solid tumors
by: Bowen Jiang, et al.
Published: (2023-02-01) -
Editorial: Liquid biopsy as a tool for precision oncology: New challenges to assess clinical response, Volume II
by: Paola Ulivi
Published: (2023-04-01) -
Liquid Biopsy in Neurological Diseases
by: Sunny Malhotra, et al.
Published: (2023-07-01)